Home | Breaking Out | AI powered stock trade ideas | Bullish Engulfing | Market Signals | New Green Signal Stocks | Recent Red Arrow Top Signals | Recent Green Arrow Bottom Signals | Near Term Bottom Signals | Green Stocks with Most Upside to Analyst Target Price | New Long Term Green AI Signals | Big Tech Stocks | ETF Sector SPDRs | Solar Stocks | Chip Stocks | Airline Stocks | Social Media Stocks | Oil Stocks| Discount Store Stocks | Entertainment Stocks | EV Stocks | Restaurant Stocks | Heavy Equipment Stocks | Aerospace Stocks | Home Builders | Bank Stock Signals | Cruise Ship Stock Signals | Mining Stocks | Free AI Portfolio Analyzer | How to Read and Trade AI Powered Stock Charts| Stock Charts AI top 50 Stocks

AI Options Trading Bot (BETA)
Enter Stock Symbol to View AI powered Stock Chart

StockChartsAI.com

All Chart Prices Delayed at least 15 minutes

Before accessing this site, you agree that you have read and agree to the disclaimers at the bottom of this page.


Stock Charts AI Power Rank: 9.2
Power Rank trend -> Rising

Last Price: 50.72 - Change: 0.56 - Change %: 1.1164
02/12/2025 16:00:00 EST

Mirum Pharmaceuticals Inc (MIRM)

Industry: Biotechnology

Price Support Resistance

In the past 20 trading days, MIRM has been trading in a range between $50.21 and $41.32 (gray range band). Red lines on the chart represent key resistance levels and Green lines represent key support levels. As the price moves above the lines you will notice they turn green and red if price moves below a line.

MIRM is breaking above top of the recent 20 day range at $50.21 and appears that it could have some more upside. If it enters a yellow zone the trend may be faltering - consider exiting or taking profits. If it enters a red zone on the chart we would exit the position.

Upside / Downside Potential

Mirum Pharmaceuticals Inc $MIRM entered a Green zone 21 days ago on the AI powered stock chart. Wall Street analysts have an AVG target price $62.3, a potential upside of 22.01% from the recent price of 51.06. The stock is trading 4.76% (potential upside) below its 52 week high of $53.49 and 120.66 % (potential downside) above its 52 week low of $23.14 - based on the recent price.

Company Summary

Mirum Pharmaceuticals, Inc, a biopharmaceutical company, focuses on the development and commercialization of novel therapies for debilitating rare and orphan diseases. Its lead product candidate is LIVMARLI (maralixibat), an orally administered and minimally absorbed ileal bile acid transporter (IBAT) inhibitor that is approved for the treatment of cholestatic pruritus in patients with Alagille syndrome in the United States and internationally.

MIRM Website

News

Mirum Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
FOSTER CITY, Calif.--(BUSINESS WIRE)--Mirum Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4).
Source: Business Wire
Mon, 10 Feb 2025 19:00:00 -0500
Sentiment: Neutral
Recent Price Trend in Mirum Pharmaceuticals (MIRM) is Your Friend, Here's Why
Mirum Pharmaceuticals (MIRM) made it through our "Recent Price Strength" screen and could be a great choice for investors looking to make a profit from stocks that are currently on the move.
Source: Zacks Investment Research
Thu, 30 Jan 2025 09:50:46 -0500
Sentiment: Positive
Mirum Pharmaceuticals (MIRM) Upgraded to Buy: What Does It Mean for the Stock?
Mirum Pharmaceuticals (MIRM) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Source: Zacks Investment Research
Fri, 24 Jan 2025 13:01:13 -0500
Sentiment: Positive
MIRM Shares Rise 12% in a Week on Robust Preliminary 2024 Results
Mirum stock rallies this week on upbeat preliminary 2024 results, the 2025 outlook and anticipated pipeline goals.
Source: Zacks Investment Research
Thu, 16 Jan 2025 13:11:08 -0500
Sentiment: Positive
Mirum Pharmaceuticals (MIRM) Is a Great Choice for 'Trend' Investors, Here's Why
If you are looking for stocks that are well positioned to maintain their recent uptrend, Mirum Pharmaceuticals (MIRM) could be a great choice. It is one of the several stocks that passed through our "Recent Price Strength" screen.
Source: Zacks Investment Research
Tue, 14 Jan 2025 09:51:14 -0500
Sentiment: Positive
Instituions Institution %: 115.476
Last QTR Institution change: -1514804

Insiders
Insiders %: 2.775
Insiders Purchases last QTR: 4345
Insiders Sales last QTR: 83652
Insiders Net last QTR: -79307

Analyst Ratings
Target Price: 62.3
Overall Rating: 4.6
Strong Buys (5): 6
Buys (4): 4
Holds (3): 0
Sells (2): 0
Strong Sells (1): 0

Technicals
52 Week Hi: 53.49
52 Week Low: 23.14
Beta: 1.162
50 Day MA: 45.2159
200 Day MA: 38.4615

Earnings / Revenue Trends
Qtr Earnings Growth YOY: 0
Qtr Revenue Growth YOY: 0.894
Forward PE: 72.4638
Trailing PE: 0

Benefits of StockChartsAI.com System:

  • Get a Daily List of Stocks Starting New Trends
  • Upload Your Stocks to Quickly See and Track Signals
  • Easy to Understand AI Stock Signals
  • Analysis of Historical Signal Trend Analysis for each stock
  • Search/View AI Stock Signals of Russel 1000 Stocks
  • Easy to Understand AI Stock Signals
  • And MUCH MUCH more!

1000

Stock Analyzed Each Night

Portfolio

Easily Upload Track Your Stocks

Trends

See Lists of Stocks Starting New Trends

The information contained on this website is solely for educational purposes, and does not constitute investment advice. The risk of trading in securities markets can be substantial. By accessing this site, you agree we are not liable, whether in contract, tort (including negligence) or otherwise, in respect of any damage, expense or other loss you may suffer arising out of such information or any reliance you may place upon such information from this site. Stocks, Futures and options trading has large potential rewards, but also large potential risk. You must be aware of the risks and be willing to accept them in order to invest in the stock, futures and options markets. Don't trade with money you can't afford to lose. This website is neither a solicitation nor an offer to Buy/Sell futures or options. No representation is being made that any account will or is likely to achieve profits or losses similar to those discussed on this website. The past performance of any trading system or methodology is not necessarily indicative of future results. Individual results may vary, and testimonials are not claimed to represent typical results. All testimonials are by real people, and may not reflect the typical purchaser’s experience, and are not intended to represent or guarantee that anyone will achieve the same or similar results. HYPOTHETICAL OR SIMULATED PERFORMANCE RESULTS HAVE CERTAIN LIMITATIONS. UNLIKE AN ACTUAL PERFORMANCE RECORD, SIMULATED RESULTS DO NOT REPRESENT ACTUAL TRADING. ALSO, SINCE THE TRADES HAVE NOT BEEN EXECUTED, THE RESULTS MAY HAVE UNDER-OR-OVER COMPENSATED FOR THE IMPACT, IF ANY, OF CERTAIN MARKET FACTORS, SUCH AS LACK OF LIQUIDITY, SIMULATED TRADING PROGRAMS IN GENERAL ARE ALSO SUBJECT TO THE FACT THAT THEY ARE DESIGNED WITH THE BENEFIT OF HINDSIGHT. NO REPRESENTATION IS BEING MADE THAT ANY ACCOUNT WILL OR IS LIKELY TO ACHIEVE PROFIT OR LOSSES SIMILAR TO THOSE SHOWN.